Design and Rationale of the Phase II PANDORA Trial: First Line Chemo-Immunotherapy in Advanced Merkel Cell Carcinoma.
Simone Oldani,Natalie Prinzi,Federica Morano,Sara Cingarlini,Anna Maria Di Giacomo,Monica Niger,Michele Prisciandaro,Alessandra Raimondi,Giovanni Randon, Chiara Carlotta Pircher, Michele Borghesani,Monica Valente, Elvira Rostanzo,Massimo Milione,Giovanna Sabella,Tommaso Cascella,Filippo Ghelardi, Carolina Sciortino, Eleonora Gusmaroli, Vincenzo Nasca, Filippo de Braud,Filippo Pietrantonio,Sara Pusceddu Future oncology (London, England)（2025）
AI 理解论文
溯源树
样例
